Status:
RECRUITING
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
Lead Sponsor:
Syracuse University
Collaborating Sponsors:
State University of New York - Upstate Medical University
Conditions:
Obesity and Type 2 Diabetes
Metabolic Diseases
Eligibility:
All Genders
14-30 years
Phase:
NA
Brief Summary
The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on cardiometabolic bioma...
Detailed Description
As of 2015, an estimated 2 billion individuals were overweight (body mass index \[BMI\] ≥ 25 kg/m2), and one-third of them were obese (BMI ≥ 30 kg/m2). Obesity has become a serious health concern due ...
Eligibility Criteria
Inclusion
- Adolescents (age 14-17 years old with sex- and race-specific BMI percentile ≥85th) and young adults with overweight and obesity (age 18 to 30 years old with BMI ≥25 kg/m2)
Exclusion
- Chronic medical conditions: heart disease, arrhythmias, diabetes, thyroid disease, bleeding disorder, history of pulmonary disease, hypertension, hepatorenal disease, musculoskeletal disorder, neuromuscular/neurological disease, autoimmune disease, cancer, peptic ulcers, anemia, or chronic infection (HIV).
- Have taken any heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti- hypertensive, endocrinologic (e.g., thyroid, insulin, etc.), emotional/psychotropic (e.g., Prednisone, Ritalin, Adderall), neuromuscular/neurological, or androgenic medications (anabolic steroids).
- Have a pacemaker.
Key Trial Info
Start Date :
March 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07215533
Start Date
March 15 2024
End Date
December 30 2025
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Syracuse University
Syracuse, New York, United States, 13244